Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 60
Filter
1.
Arq. ciências saúde UNIPAR ; 23(3): 221-226, set-dez. 2019.
Article in Portuguese | LILACS | ID: biblio-1046191

ABSTRACT

A Organização Mundial de Saúde (OMS) aponta as doenças cardiovasculares como a principal causa de morte no mundo, caracterizando um grave problema na saúde pública. Os três tipos de doenças que mais acarretam em óbito são: acidente vascular cerebral, seguido de infarto agudo do miocárdio e outras doenças isquêmicas do coração.Apesar dos avanços terapêuticos das últimas décadas, o infarto ainda apresenta altas taxas de mortalidade. Para as pessoas com doenças cardiovasculares ou com alto risco cardiovascular é fundamental o diagnóstico precoce da doença. A cintilografia de perfusão miocárdica é um método de investigação diagnóstica e prognóstico não invasivo de várias doenças cardiovasculares. Esse exame consiste na administração de um radiofármaco para obtenção de imagens de perfusão cardíaca. Dois traçadores marcados com Tecnécio-99m são amplamente utilizados na clínica, porém, esses dois radiofármacos não atendem aos requisitos de um agente de perfusão ideal, por sofrerem significativa excreção biliar, produzindo artefatos na imagem, o que pode inteferir um diagnóstico preciso, já que a qualidade é comprometida, e prolongando o tempo de obtenção da imagem após a administração do radiotraçador. Para superar essa lacuna, pesquisadores vêm estudando novos complexos catiônicos marcados com o Tecnécio. O objetivo desse artigo é fazer uma revisão, abordando a literatura sobre os radiofármacos que estão sendo estudados, suas vantagens e desvantagens sobre os traçadores já utilizados, e sobre sua potencial utilização na obtenção de imagem de perfusão cardíaca.


The World Health Organization (WHO) acknowledges cardiovascular diseases as the leading cause of death in the world, being regarded as a serious public health issue. The three types of diseases with the greatest mortality are: stroke, followed by acute myocardial infarction (AMI) and other ischemic heart diseases. Despite the therapeutic advances of the last decades, AMI still presents high mortality rates. Early diagnosis is essential for people with cardiovascular diseases or with a high cardiovascular risk. Myocardial perfusion scintigraphy is a method of diagnostic investigation and noninvasive prognosis of various cardiovascular diseases. This examination consists in the administration of a radiopharmaceutical drug to obtain images of cardiac perfusion. Two tracers labeled with Technetium-99m are widely used, however, these two radiopharmaceuticals do not meet the requirements of an ideal perfusion agent, because they have a high liver absorption, producing artifacts in the image, which can disrupt a precise diagnosis, since the quality is compromised, and prolonging the imaging time after administration of the radioisotope. To overcome this gap, researchers have been studying new cationic complexes marked with technetium. The objective of this article is to review the literature on the radiopharmaceuticals being studied, their advantages and disadvantages on the tracers already used, and their potential use in obtaining a cardiac perfusion image.


Subject(s)
Technetium/pharmacokinetics , Radiopharmaceuticals/pharmacokinetics , Myocardial Perfusion Imaging/instrumentation , Radioactive Tracers , Cardiovascular Diseases/diagnostic imaging , Radionuclide Imaging/instrumentation , Technetium Tc 99m Sestamibi/adverse effects , Cardiac Imaging Techniques/instrumentation , Liver/drug effects , Myocardial Infarction/diagnostic imaging
3.
Rev. méd. Chile ; 146(4): 413-421, abr. 2018. tab, graf
Article in Spanish | LILACS | ID: biblio-961411

ABSTRACT

Background: Pancreatic cancer is the tenth most prevalent cancer in world, and represents the fourth cause of cancer death. It has a five year-survival of 5%. Aim: To assess the prognostic value of PET/CT in pancreatic cancer. Material and Methods: Sixty-nine patients with pancreatic adenocarcinoma who underwent staging 18F-fluorodeoxyglucose (FDG) PET/CT between December 2008 and July 2016 were selected. Gender, age, body-mass index, laboratory tests (Ca 19-9, hemoglobin, erythrocyte sedimentation rate, liver enzymes, lactate dehydrogenase), histological differentiation of tumor, American Joint Committee on Cancer (AJCC) stage, size and 18F-FDG uptake (maximal stan-dardized uptake value [SUVmax]) of the primary tumor, nodal involvement and distant metastasis detected by PET/CT were registered. Survival was assessed using Kaplan-Meier curves, Log Rank test and Cox multivariable analysis. Results: Mortality was 66.7%, during a mean observation time of 18 months (range 20 days-66 months). Curative surgery, lack of metastases detected by PET/CT, histologically well differentiated tumors, and SUVmax ≤ 4.3 were significantly associated with a better specific survival, determined by the Log Rank test. Histological differentiation was the only variable that had a statistically significant prognostic value in the multivariable analysis. Conclusions: The detection of distant metastases and the intensity of primary tumor 18F-FDG uptake during PET/CT provide useful prognostic information in pancreatic cancer patients.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Pancreatic Neoplasms/diagnostic imaging , Adenocarcinoma/diagnostic imaging , Pancreatic Neoplasms/mortality , Pancreatic Neoplasms/pathology , Prognosis , Time Factors , Adenocarcinoma/mortality , Adenocarcinoma/pathology , Survival Analysis , Retrospective Studies , Follow-Up Studies , Radiopharmaceuticals/administration & dosage , Radiopharmaceuticals/pharmacokinetics , Fluorodeoxyglucose F18/administration & dosage , Fluorodeoxyglucose F18/pharmacokinetics , Tumor Burden , Neoplasm Grading , Positron Emission Tomography Computed Tomography/methods
4.
J. bras. pneumol ; 42(6): 404-408, Nov.-Dec. 2016. tab, graf
Article in English | LILACS | ID: biblio-841245

ABSTRACT

ABSTRACT Objective: To evaluate the effects of positive expiratory pressure (PEP) on pulmonary epithelial membrane permeability in healthy subjects. Methods: We evaluated a cohort of 30 healthy subjects (15 males and 15 females) with a mean age of 28.3 ± 5.4 years, a mean FEV1/FVC ratio of 0.89 ± 0.14, and a mean FEV1 of 98.5 ± 13.1% of predicted. Subjects underwent technetium-99m-labeled diethylenetriaminepentaacetic acid (99mTc-DTPA) radioaerosol inhalation lung scintigraphy in two stages: during spontaneous breathing; and while breathing through a PEP mask at one of three PEP levels-10 cmH2O (n = 10), 15 cmH2O (n = 10), and 20 cmH2O (n = 10). The 99mTc-DTPA was nebulized for 3 min, and its clearance was recorded by scintigraphy over a 30-min period during spontaneous breathing and over a 30-min period during breathing through a PEP mask. Results: The pulmonary clearance of 99mTc-DTPA was significantly shorter when PEP was applied-at 10 cmH2O (p = 0.044), 15 cmH2O (p = 0.044), and 20 cmH2O (p = 0.004)-in comparison with that observed during spontaneous breathing. Conclusions: Our findings indicate that PEP, at the levels tested, is able to induce an increase in pulmonary epithelial membrane permeability and lung volume in healthy subjects.


RESUMO Objetivo: Avaliar os efeitos da pressão expiratória positiva (PEP) na permeabilidade da membrana epitelial pulmonar em indivíduos saudáveis. Métodos: Foi avaliada uma coorte de 30 indivíduos saudáveis (15 homens e 15 mulheres), com média de idade de 28,3 ± 5,4 anos, média da relação VEF1/CVF de 0,89 ± 0,14 e média de VEF1 de 98,5 ± 13,1% do previsto. Os indivíduos foram submetidos a cintilografia pulmonar por inalação de radioaerossol de ácido dietilenotriaminopentacético marcado com tecnécio-99m (99mTc-DTPA em inglês) em dois estágios: durante respiração espontânea e durante respiração com uma máscara de PEP de 10 cmH2O (n = 10), 15 cmH2O (n = 10) ou 20 cmH2O (n = 10). O 99mTc-DTPA foi nebulizado por 3 min, e sua depuração foi registrada por cintilografia por um período de 30 min durante respiração espontânea e por um período de 30 min durante a respiração com uma máscara de PEP. Resultados: A depuração pulmonar do 99mTc-DTPA foi significativamente menor quando PEP foi aplicada a 10 cmH2O (p = 0,044), 15 cmH2O (p = 0,044) e 20 cmH2O (p = 0,004), em comparação com a observada durante a respiração espontânea. Conclusões: Nossos achados indicam que o uso de PEP nos níveis testados pode induzir um aumento na permeabilidade da membrana epitelial pulmonar e no volume pulmonar em indivíduos saudáveis.


Subject(s)
Humans , Female , Adult , Lung/metabolism , Positive-Pressure Respiration/methods , Radiopharmaceuticals/pharmacokinetics , Technetium Tc 99m Pentetate/pharmacokinetics , Lung/physiology , Metabolic Clearance Rate , Permeability , Pulmonary Alveoli/metabolism , Radiopharmaceuticals/administration & dosage , Technetium Tc 99m Pentetate/administration & dosage
5.
Yonsei Medical Journal ; : 232-237, 2016.
Article in English | WPRIM | ID: wpr-220777

ABSTRACT

PURPOSE: Both 18F-fluorodeoxyglucose (18F-FDG) uptake and epidermal growth factor receptor (EGFR) status are prognostic variables of colorectal cancer (CRC). The aim of this study was to investigate a possible association between 18F-FDG uptake on preoperative positron emission tomography/computed tomography (PET/CT) and EGFR status in primary CRC. MATERIALS AND METHODS: Records of 132 patients (66 men and 66 women; mean age=67.1+/-11.1 years) who underwent 18F-FDG PET/CT for CRC staging and subsequent bowel resection were reviewed. In primary lesions, 18F-FDG uptake was semiquantitatively evaluated in terms of maximum standardized uptake value (SUVmax), and EGFR status was determined by immunohistochemistry. Associations of clinicopathological parameters and EGFR status were analyzed by Pearson's chi-square test, multiple logistic regression, and receiver operating characteristic curves. RESULTS: Eighty-six patients (65.2%) showed EGFR expression. SUVmax was significantly lower in EGFR-negative tumors than in EGFR-expressing tumors (10.0+/-4.2 vs. 12.1+/-2.1; p=0.012). It was the only significant parameter correlated with EGFR expression (odds ratio=2.457; relative risk=2.013; p=0.038). At the SUVmax threshold of 7.5, the sensitivity and specificity for predicting EGFR expression were 84.9% and 40.4%, respectively (area under the curve=0.624; p=0.019). CONCLUSION: Preoperative 18F-FDG uptake is slightly correlated with EGFR status in primary CRC. Preoperative SUVmax of 18F-FDG may have a limited role in predicting EGFR expression in such tumors because of its poor specificity.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Colorectal Neoplasms/metabolism , Fluorodeoxyglucose F18/pharmacokinetics , Immunohistochemistry , Multimodal Imaging/methods , Neoplasm Staging , Positron-Emission Tomography/methods , Predictive Value of Tests , Prognosis , ROC Curve , Radiopharmaceuticals/pharmacokinetics , ErbB Receptors/metabolism , Sensitivity and Specificity
6.
Journal of Gynecologic Oncology ; : e15-2016.
Article in English | WPRIM | ID: wpr-100611

ABSTRACT

OBJECTIVE: We investigated the prognostic value of intratumoral [18F]fluorodeoxyglucose (FDG) uptake heterogeneity (IFH) derived from positron emission tomography/computed tomography (PET/CT) in patients with cervical cancer. METHODS: Patients with uterine cervical cancer of the International Federation of Obstetrics and Gynecology (FIGO) stage IB to IIA were imaged with [18F]FDG PET/CT before radical surgery. PET/CT parameters such as maximum and average standardized uptake values (SUV(max) and SUV(avg)), metabolic tumor volume (MTV), total lesion glycolysis (TLG), and IFH were assessed. Regression analyses were used to identify clinicopathological and imaging variables associated with progression-free survival (PFS). RESULTS: We retrospectively reviewed clinical data of 85 eligible patients. Median PFS was 32 months (range, 6 to 83 months), with recurrence observed in 14 patients (16.5%). IFH at an SUV of 2.0 was correlated with primary tumor size (p<0.001), SUV(tumor) (p<0.001), MTV(tumor) (p<0.001), TLG(tumor) (p<0.001), depth of cervical invasion (p<0.001), and negatively correlated with age (p=0.036). Tumor recurrence was significantly associated with TLG(tumor) (p<0.001), MTV(tumor) (p=0.001), SUV(LN) (p=0.004), IFH (p=0.005), SUV(tumor) (p=0.015), and FIGO stage (p=0.015). Multivariate analysis identified that IFH (p=0.028; hazard ratio, 756.997; 95% CI, 2.047 to 279,923.191) was the only independent risk factor for recurrence. The Kaplan-Meier survival graphs showed that PFS significantly differed in groups categorized based on IFH (p=0.013, log-rank test). CONCLUSION: Preoperative IFH was significantly associated with cervical cancer recurrence. [18F]FDG based heterogeneity may be a useful and potential predicator of patient recurrence before treatment.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Middle Aged , Carcinoma, Squamous Cell/metabolism , Disease-Free Survival , Fluorodeoxyglucose F18/pharmacokinetics , Glycolysis , Multimodal Imaging , Neoplasm Invasiveness , Neoplasm Recurrence, Local/metabolism , Neoplasm Staging , Positron-Emission Tomography , Predictive Value of Tests , Radiopharmaceuticals/pharmacokinetics , Retrospective Studies , Tomography, X-Ray Computed , Tumor Burden , Uterine Cervical Neoplasms/metabolism
7.
Acta cir. bras ; 30(6): 388-393, 06/2015. tab
Article in English | LILACS | ID: lil-749643

ABSTRACT

PURPOSE: To evaluate the heart and the Tc-99m-sestamibi biodistribution after statin pretreatment in a rat model of abdominal sepsis. METHODS: Twenty-four Wistar rats were randomly distributed into four groups (n=6 per group): 1) sepsis with simvastatin treatment, 2) sepsis with vehicle, 3) sham control with simvastatin and 4) sham control with vehicle. 24 hours after cecal ligation and puncture rats received 1.0MBq of Tc-99m-sestamibi i.v. 30min after, animals were euthanized for ex-vivo tissue counting and myocardium histological analysis. RESULTS: Myocardial histologic alterations were not detected 24 hours post-sepsis. There was significantly increased cardiac Tc-99m-sestamibi activity in the sepsis group with simvastatin treatment (1.9±0.3%ID/g, p<0.001) in comparison to the sepsis group+vehicle (1.0±0.2%ID/g), control sham group+ simvastatin (1.2±0.3%ID/g) and control sham group (1.3±0.2%ID/g). Significant Tc-99m-sestamibi activity in liver, kidney and lungs was also detected in the sepsis group treated with simvastatinin comparison to the other groups. CONCLUSIONS: Statin treatment altered the biodistribution of Tc-99m-sestamibi with increased cardiac and solid organ activity in rats with abdominal sepsis, while no impact on controls. Increased myocardial tracer activity may be a result of a possible protection effect due to increased tissue perfusion mediated by statins. .


Subject(s)
Animals , Heart/drug effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Intraabdominal Infections/drug therapy , Sepsis/drug therapy , Simvastatin/therapeutic use , Disease Models, Animal , Heart , Intraabdominal Infections/complications , Kidney/drug effects , Kidney , Liver/drug effects , Liver , Lung/drug effects , Lung , Random Allocation , Rats, Wistar , Reproducibility of Results , Radiopharmaceuticals/pharmacokinetics , Sepsis/complications , Time Factors , Treatment Outcome , /pharmacokinetics
8.
Journal of Korean Medical Science ; : 1232-1240, 2015.
Article in English | WPRIM | ID: wpr-120931

ABSTRACT

Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) may be a promising modality for treating medial temporal lobe epilepsy. 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a noninvasive method for monitoring in vivo glucose metabolism. We evaluated the efficacy of hUCB-MSCs transplantation in chronic epileptic rats using FDG-PET. Rats with recurrent seizures were randomly assigned into three groups: the stem cell treatment (SCT) group received hUCB-MSCs transplantation into the right hippocampus, the sham control (ShC) group received same procedure with saline, and the positive control (PC) group consisted of treatment-negative epileptic rats. Normal rats received hUCB-MSCs transplantation acted as the negative control (NC). FDG-PET was performed at pre-treatment baseline and 1- and 8-week posttreatment. Hippocampal volume was evaluated and histological examination was done. In the SCT group, bilateral hippocampi at 8-week after transplantation showed significantly higher glucose metabolism (0.990 +/- 0.032) than the ShC (0.873 +/- 0.087; P < 0.001) and PC groups (0.858 +/- 0.093; P < 0.001). Histological examination resulted that the transplanted hUCB-MSCs survived in the ipsilateral hippocampus and migrated to the contralateral hippocampus but did not differentiate. In spite of successful engraftment, seizure frequency among the groups was not significantly different. Transplanted hUCB-MSCs can engraft and migrate, thereby partially restoring bilateral hippocampal glucose metabolism. The results suggest encouraging effect of hUCB-MSCs on restoring epileptic networks.


Subject(s)
Animals , Male , Rats , Chronic Disease , Cord Blood Stem Cell Transplantation/methods , Epilepsy, Temporal Lobe/metabolism , Fluorodeoxyglucose F18/pharmacokinetics , Hippocampus/metabolism , Mesenchymal Stem Cell Transplantation/methods , Radiopharmaceuticals/pharmacokinetics , Rats, Sprague-Dawley , Reproducibility of Results , Sensitivity and Specificity , Tissue Distribution , Treatment Outcome
9.
Korean Journal of Urology ; : 288-294, 2015.
Article in English | WPRIM | ID: wpr-34599

ABSTRACT

PURPOSE: To investigate the prevalence and clinical significance of incidental prostate fluoro-2-deoxyglucose (FDG) uptake and to evaluate its impact on patient management. MATERIALS AND METHODS: Of 47,109 men who underwent FDG positron emission tomography between 2004 and 2014, 1,335 (2.83%) demonstrated incidental FDG uptake in the prostate, with 99 of the latter undergoing prostate biopsy. The primary end point was the histological presence of prostate adenocarcinoma in the biopsy specimen. Outcomes, including treatment methods, survival, and causes of death, were also assessed. Factors associated with the diagnosis of prostate cancer were evaluated by using logistic regression analysis. RESULTS: Patients with prostate cancer were more likely to have higher serum prostate-specific antigen (PSA) (p=0.001) and focal FDG uptake (p=0.036) than were those without. Prostate cancer occurred in 1 of 26 patients (3.8%) with serum PSA or =2.5 ng/mL. Multivariable analysis showed that focal lesions (odds ratio [OR], 5.50; p=0.038), age (OR, 1.06; p=0.031), and serum PSA (OR, 1.28; p=0.001) were independent predictors of prostate cancer diagnosis. Most patients with prostate cancer had organ-confined tumors. Of these, 12 (29.3%) underwent radical prostatectomy and 25 (60.9%) received hormone therapy. Of the 11 patients who died, 9 died of primary cancer progression, with only 1 patient dying from prostate cancer. CONCLUSIONS: The prevalence of incidental FDG uptake in the prostate was not high, although patients with elevated serum PSA had a higher incidence of prostate cancer. Patients with FDG uptake in the prostate should be secondarily evaluated by measuring serum PSA, with those having high serum PSA undergoing prostate biopsy.


Subject(s)
Aged , Humans , Male , Middle Aged , Adenocarcinoma/epidemiology , Biopsy , Fluorodeoxyglucose F18/pharmacokinetics , Incidental Findings , Organ Specificity , Positron-Emission Tomography/adverse effects , Prevalence , Prostate/drug effects , Prostatectomy/methods , Prostatic Neoplasms/epidemiology , Radiopharmaceuticals/pharmacokinetics , Republic of Korea/epidemiology , Retrospective Studies , Tissue Distribution
10.
Arq. bras. endocrinol. metab ; 58(9): 889-899, 12/2014. tab
Article in English | LILACS | ID: lil-732180

ABSTRACT

Brown adipose tissue, an essential organ for thermoregulation in small and hibernating mammals due to its mitochondrial uncoupling capacity, was until recently considered to be present in humans only in newborns. The identification of brown adipose tissue in adult humans since the development and use of positron emission tomography marked with 18-fluorodeoxyglucose (PET-FDG) has raised a series of doubts and questions about its real importance in our metabolism. In this review, we will discuss what we have learnt since its identification in humans as well as both new and old concepts, some of which have been marginalized for decades, such as diet-induced thermogenesis. Arq Bras Endocrinol Metab. 2014;58(9):889-99.


O tecido adiposo marrom, órgão essencial para a termorregulação de animais hibernantes e pequenos devido à sua capacidade desacopladora, era até poucos anos considerado presente apenas em recém-nascidos na espécie humana. A identificação do tecido adiposo marrom em adultos com o desenvolvimento e uso da tomografia de emissão de pósitron marcado com 18-fluorodesoxiglicose (PET-FDG) gerou questões sobre sua real importância para nosso metabolismo. Nesta revisão, discutiremos o que aprendemos nesse tempo, assim como conceitos antigos e novos, alguns marginalizados por décadas, como a termogênese induzida por dieta. Arq Bras Endocrinol Metab. 2014;58(9):889-99.


Subject(s)
Adult , Humans , Adipose Tissue, Brown/physiology , Ion Channels/metabolism , Mitochondrial Proteins/metabolism , Adipose Tissue, Brown/drug effects , Adipose Tissue, Brown/metabolism , Energy Metabolism/physiology , /pharmacokinetics , Obesity/metabolism , Positron-Emission Tomography/methods , Radiopharmaceuticals/pharmacokinetics , Thermogenesis/physiology
11.
Clinics ; 67(2): 163-170, 2012. ilus, graf, tab
Article in English | LILACS | ID: lil-614641

ABSTRACT

OBJECTIVES: Scintigraphy is generally not the first choice treatment for prostate cancer, although successful studies using bombesin analog radiopeptides have been performed. Recently, a novel peptide obtained using a phage display library demonstrated an affinity for prostate tumor cells. The aim of this study was to compare the use of a bombesin analog to that of a phage display library peptide (DUP-1) radiolabeled with technetium-99m for the treatment of prostate carcinoma. The peptides were first conjugated to S-acetyl-MAG3 with a 6-carbon spacer, namely aminohexanoic acid. METHODS: The technetium-99m labeling required a sodium tartrate buffer. Radiochemical evaluation was performed using ITLC and was confirmed by high-performance liquid chromatography. The coefficient partition was determined, and in vitro studies were performed using human prostate tumor cells. Biodistribution was evaluated in healthy animals at various time points and also in mice bearing tumors. RESULTS: The radiochemical purity of both radiotracers was greater than 95 percent. The DUP-1 tracer was more hydrophilic (log P = -2.41) than the bombesin tracer (log P = -0.39). The biodistribution evaluation confirmed this hydrophilicity by revealing the greater kidney uptake of DUP-1. The bombesin concentration in the pancreas was greater than that of DUP-1 due to specific gastrin-releasing peptide receptors. Bombesin internalization occurred for 78.32 percent of the total binding in tumor cells. The DUP-1 tracer showed very low binding to tumor cells during the in vitro evaluation, although tumor uptake for both tracers was similar. The tumors were primarily blocked by DUP1 and the bombesin radiotracer primarily targeted the pancreas. CONCLUSION: Further studies with the radiolabeled DUP-1 peptide are recommended. With further structural changes, this molecule could become an efficient alternative tracer for prostate tumor diagnosis.


Subject(s)
Animals , Humans , Male , Mice , Aminocaproates/chemistry , Bombesin , Oligopeptides/chemistry , Peptides , Prostatic Neoplasms , Radiopharmaceuticals , Technetium , Aminocaproates/pharmacokinetics , Bombesin/analogs & derivatives , Culture Media , Disease Models, Animal , Isotope Labeling/methods , Mice, Nude , Oligopeptides/pharmacokinetics , Pancreas , Random Allocation , Radiopharmaceuticals/chemistry , Radiopharmaceuticals/pharmacokinetics , Receptors, Bombesin/analysis , Receptors, Bombesin/metabolism , Biomarkers, Tumor/metabolism
12.
Acta cir. bras ; 26(6): 503-507, Nov.-Dec. 2011. ilus, tab
Article in English | LILACS | ID: lil-604201

ABSTRACT

PURPOSE: To investigate the influence of partial colectomy associated with hepatectomy on the biodistribution of the 99mTc-phytate, on metabolic parameters, as well as labeling and morphology of red blood cells. METHODS: Wistar rats were distributed into three groups (each with six), nominated as colectomy, colectomy+hepatectomy and sham. In the 30th postoperative day all rats were injected with 99mTc-phytate 0.1mL i.v. (radioactivity 0.66 MBq). After 15 minutes, liver sample was harvested and weighed. Percentage radioactivity per gram of tissue ( percentATI/g) was determined using an automatic gamma-counter. Serum AST, ALT, alkaline phosphatase and red blood cells labeling were determined. RESULTS: The liver percentATI/g and red blood cells labeling were lower in colectomy and colectomy+hepatectomy rats than in sham rats (p <0.05), and no difference was detected comparing the colectomy and colectomy+hepatectomy groups. Red blood cells morphology did not differ among groups. Serum levels of AST, ALT and alkaline fosfatase were significantly higher in colectomy+hepatectomy than in colectomy rats (p<0.001). CONCLUSION: Hepatectomy associated with colectomy lowered the uptake of radiopharmaceutical in liver and in red blood cells in rats, coinciding with changes in liver enzymatic activity.


OBJETIVO: Investigar a influência da colectomia associada à hepatectomia parcial, na biodistribuição do fitato-99mTcO4, na marcação e morfologia de hemácias e em parâmetros metabólicos. MÉTODOS: Ratos Wistar foram distribuídos em três grupos (seis animais cada), denominados: colectomia, colectomia+hepatectomia e sham. No 30º dia pós-operatório, em todos eles foi feita injeção de 0,1 mL i.v. de fitato-99mTcO4 (radioatividade 0,66 MBq). Após 15 minutos, uma amostra de fígado foi colhida e pesada. O percentual de radioatividade por grama de tecido ( por centoATI/g) foi determinado no fígado e hemácias usando-se um contador gama automático. Dosagem sérica de AST, ALT, fosfatase alcalina, morfologia e marcação de hemácias com pertecnetato foram determinadas. RESULTADOS: O por centoATI/g no fígado e nas hemácias foi menor nos animais dos grupos colectomia e colectomia+hepatectomia do que no grupo sham (p<0,05; teste de Tukey). Nenhuma diferença foi detectada comparando os grupos colectomia e colectomia+hepatectomia. A morfologia das hemácias não diferiu entre os três grupos. Os níveis séricos de AST, ALT e fosfatase alcalina foram significativamente maiores no grupo colectomia+hepatectomia do que no grupo colectomia (p<0,001). CONCLUSÃO: A colectomia associada a hepatectomia contribuiu para reduzir a captação de radiofármaco no fígado e hemácias de ratos, coincidindo com alterações na atividade enzimática do fígado.


Subject(s)
Animals , Rats , Colectomy , Erythrocytes/metabolism , Hepatectomy , Liver/metabolism , Radiopharmaceuticals/pharmacokinetics , /pharmacokinetics , Alanine Transaminase/blood , Alkaline Phosphatase/blood , Aspartate Aminotransferases/blood , Random Allocation , Rats, Wistar , Tissue Distribution
13.
Acta cir. bras ; 26(5): 339-345, Sept.-Oct. 2011. graf, tab
Article in English | LILACS | ID: lil-599634

ABSTRACT

PURPOSE: People consume vegetables without the knowledge of the side effects of the biological and chemical contents and interactions between radiopharmaceuticals and herbal extract. To this end, current study is focused on the effects of broccoli extract on biodistribution of radiolabeled glucoheptonate (99mTc-GH) and radiolabeling of blood components. METHODS: GH was labeled with 99mTc. Quality control studies were done utilizing TLC method. Biodistribution studies were performed on male rats which were treated via gavage with either broccoli extract or SF as control group for 15 days. Blood samples were withdrawn from rats' heart. Radiolabeling of blood constituents performed incubating with GH, SnCl2 and 99m Tc. RESULTS: Radiochemical yield of 99mTc-GH is 98.46±1.48 percent (n=8). Biodistribution studies have shown that according to the control, the treated group with broccoli has approximately 10 times less uptake in kidney. The percentage of the radioactivity ratios of the blood components is found to be same in both groups. CONCLUSIONS: Although there is no considerable effect on the radiolabeling of blood components, there is an outstanding change on the biodistribution studies especially on kidneys. The knowledge of this change on kidney uptake may contribute to reduce the risk of misdiagnosis and/or repetition of the examinations in Nuclear Medicine.


OBJETIVO: As pessoas consomem verduras sem o conhecimento dos efeitos colaterais dos conteúdos biológicos e químicos e interações entre os medicamentos radiofarmacêuticos e os extratos vegetais. Para este fim, o estudo atual é focado sobre os efeitos do extrato de brócolis na biodistribuição do fármaco glucoheptonato (99mTc-GH) e da marcação de componentes do sangue. MÉTODOS: GH foi marcado com 99mTc. Estudos de controle de qualidade foram feitos utilizando o método do TLC. Os estudos de biodistribuição foram realizados em ratos machos que foram tratados por gavagem com um extrato de brócolis ou SF como grupo controle para 15 dias. Amostras de sangue foram retiradas do coração de ratos. Marcação de constituintes sanguíneos realizados incubação com SnCl2 GH e 99mTc. RESULTADOS: Radioquímica rendimento de 99mTc-GH é 98,46 ± 1,48 por cento (n = 8). Os estudos de biodistribuição mostraram que de acordo com o controle, o grupo tratado com brócolis tem aproximadamente 10 vezes menor absorção no rim. O percentual do ratio de radioatividade dos componentes do sangue é encontrado para ser igual nos dois grupos. CONCLUSÕES: Embora não haja nenhum efeito considerável sobre a marcação dos componentes do sangue há uma mudança notável na biodistribuição especialmente nos rins. O conhecimento desta mudança na captação de rim pode contribuir para reduzir o risco de erro diagnóstico e/ou a repetição dos exames de Medicina Nuclear.


Subject(s)
Animals , Male , Rats , Blood Cells/metabolism , Brassica/chemistry , Organotechnetium Compounds/pharmacokinetics , Plant Extracts/pharmacokinetics , Radiopharmaceuticals/pharmacokinetics , Sugar Acids/pharmacokinetics , Organ Specificity , Organotechnetium Compounds/blood , Plant Extracts/blood , Rats, Wistar , Radiopharmaceuticals/blood , Sugar Acids/blood , Time Factors , Tissue Distribution
14.
Rev. med. nucl. Alasbimn j ; 14(54)oct. 2011. ilus, tab, graf
Article in Spanish | LILACS | ID: lil-609895

ABSTRACT

El objetivo consistió en evaluar la utilidad del 99mTc-MIBI como marcador para diagnóstico y seguimiento de la progresión tumoral del NMSC en un modelo de carcinogénesis completa en ratones. Los animales en estudio fueron inyectados con 99mTc-MIBI a diferentes tiempos y eutanasiados. Se disecaron muestras de tumor y piel sana para evaluar la captación del radiofármaco y realizar el diagnóstico histológico. En animales con 22 semanas de progresión tumoral se observó una diferencia significativa en la captación del 99mTc-MIBI entre piel sana y NMSC. El protocolo que mejor se adapta al uso del 99mTc-MIBI como marcador para el diagnóstico y seguimiento de la progresión tumoral en ratones portadores de NMSC inducidos es la administración i.v de 1 mCi de 99mTc-MIBI con adquisición de datos a los 30 minutos post inyección. Se observó que a medida que los tumores progresan, la captación de 99mTc-MIBI disminuye respecto a la piel normal.


The aim of the work was to evaluate the usefulness of 99mTc-MIBI as a tracer for the tumor diagnosis and progression of NMSC in a chemically induced model in mice. After administration of 99mTc-MIBI animals were sacrificed at different times. Samples of tumor and healthy skin were dissected in order to perform histological analysis and to evaluate 99mTc-MIBI uptake. Animals under 22 weeks of tumor evolution showed a statistically difference in 99mTc-MIBI uptake between healthy skin and NMSC. Our results showed that the better protocol for the study of the tumor diagnosis and progression of NMSC in mice is the administration of 1 mCi of 99mTc-MIBI and acquisition of images 30 minutes post injection. Results showed that, as tumor progresses, the uptake of 99mTc-MIBI is significantly lower than healthy skin.


Subject(s)
Animals , Mice , Skin Neoplasms , Radiopharmaceuticals , Tissue Distribution , Time Factors , Disease Models, Animal , Radiopharmaceuticals/pharmacokinetics , /pharmacokinetics
18.
Rev. med. nucl. Alasbimn j ; 13(52)abr. 2011. tab, graf
Article in Spanish | LILACS | ID: lil-609879

ABSTRACT

Objetivo Evaluar las diferentes características diagnósticas de la función renal relativa (FRR) y de la función renal relativa normalizada por volumen renal relativo (FRRN), con el fin de analizar la posible mejora diagnóstica que implicaría su uso conjunto. Métodos Hemos estudiado con 99mTc-DMSA 952 unidades renales (riñones individuales), que pertenecían a 476 pacientes pediátricos (269 niñas) de edades comprendidas entre 0 y 11 años. De ellas, 355 unidades renales se consideraron patológicas a partir del análisis visual gammagráfico. Se determinaron los puntos de corte más apropiados para establecer los valores normales de las funciones FRR y FRRN, considerando como patrón de referencia al análisis visual gammagráfico. Se realizaron curvas ROC y se calculó el índice “J de Youden” y la exactitud para diferentes puntos de corte desde 42 por ciento hasta 50 por ciento, tanto para la FRR como para la FRRN. Se realizó también un análisis bayesiano (global y parcial clasificando las unidades renales por indicaciones clínicas) de la FRR y la FRRN. Resultados Para la FRR el mejor punto de corte fue 45 por ciento y para la FRRN fue 47 por ciento. El análisis bayesiano global mostró mejores resultados de los diferentes parámetros estadísticos para la FRRN. El análisis bayesiano parcial indicaba un importante incremento de la sensibilidad en pacientes con patología de dilatación de vía: de 10 por ciento (FRR) a 74.6 por ciento (FRRN); y con pielonefritis aguda: de 29.2 por ciento (FRR) a 66.2 por ciento (FRRN) mientras que en pacientes con nefropatías crónicas la sensibilidad fue similar (70.1 por ciento). Conclusión El cálculo de la FRRN (punto de corte 47 por ciento) proporciona información útil y complementaria a la FRR, ya que cuantifica la calidad relativa del riñón independientemente del volumen renal y refleja mejor los hallazgos gammagráficos.


Purpose To assess the different diagnostic features of relative renal function (RRF) and volume normalized relative renal function (NRRF) with the aim of analysing the possible diagnostic improvement that would imply their joint use. Methods We studied 952 kidneys with 99mTc-DMSA, belonging to 476 paediatric patients (269 girls) aged 0-11 years. 355 out of total were considered pathologic (visual analysis). The most appropriate cut-off points for establishing normality of RRF and NRRF were determined, considering as gold standard the visual scintigraphic analysis. R.O.C. curves were performed, J Youden index and accuracy were calculated for the different cut-off points from 42 percent to 50 percent for RRF and NRRF. A bayesian analysis (global and partial according to clinical indications) of RRF and NRRF was also performed. Results For RRF the better cut-off point was 45 percent and for NRRF 47 percent. The global bayesian analysis showed better values of the different statistical parameters for NRRF. Partial bayesian analysis indicated an important increment of sensitivity in patients with dilated pyelocalicial system: from 10 percent (RRF) to 74.6 percent (NRRF); and acute pyelonephritis: from 29.2 percent (RRF) to 66.2 percent (NRRF) while the sensitivity in patients with chronic nephropathy remained stable (70.1 percent). Conclusion NRRF calculation (cut-off 47 percent) provides useful and additional information to RRF, as it quantifies the relative quality of kidney tissue regardless of renal volume and better reflects better the scintigraphic findings.


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Child , Kidney Function Tests/methods , Radiopharmaceuticals , Kidney , Data Interpretation, Statistical , ROC Curve , Retrospective Studies , Radiopharmaceuticals/pharmacokinetics , Kidney/physiopathology , Kidney/metabolism , Sensitivity and Specificity , Predictive Value of Tests , /pharmacokinetics
19.
Rev. med. nucl. Alasbimn j ; 13(52)abr. 2011. ilus, tab, graf
Article in Spanish | LILACS | ID: lil-609880

ABSTRACT

La preparación de derivados de glucosa marcados con 99mTc reviste gran interés para la evaluación del consumo de glucosa in vivo en oncología y cardiología nuclear. Este trabajo presenta la marcación de un análogo de glucosa (GLU-DTC) mediante la formación de un complejo Tc(V)-nitruro simétrico. Para ello se incorporó a la biomolécula un grupo ditiocarbamato capaz de coordinar al metal. La marcación fue realizada mediante sustitución de ligandos, obteniéndose una única especie con pureza radioquímica superior al 90 por cientp, la que se mantuvo durante al menos 4 hs. La caracterización fisicoquímica y biológica muestra que el complejo 99mTc(V)-nitruro(GLU-DTC)2 es un compuesto estable y altamente hidrofílico, aunque su unión a proteínas plasmáticas es mayor a la esperada, hecho que justificaría la alta actividad retenida en sangre y en hígado durante la evaluación biológica en ratones CD1 normales. Estos resultados indican que la marcación con 99mTc de este derivado de glucosa produce una alteración significativa de su comportamiento biológico.


The preparation of 99mTc-labeled glucose derivatives is of great interest to evaluate the in vivo glucose uptake in nuclear oncology and cardiology. This paper presents the labelling of a glucose analogue (GLU-DTC) through the formation of a Tc(V)-nitride symmetrical complex. For this purpose, a dithiocarbamate group was incorporated to the biomolecule, in order to coordinate the metal. The labelling reaction was carried out by substitution yielding a single complex with radiochemical purity above 90 percent. This complex was stable for at least 4 hours. The physicochemical and biological characterization shows that the 99mTc(V)-nitride(GLU-DTC)2 complex is a stable and highly hydrophilic compound, although its plasma protein binding is greater than expected, a fact which justifies the high activity retained in blood and liver during the biological evaluation in normal CD1 mice. These results indicate that 99mTc labelling of this glucose derivate alters significantly its biological behaviour.


Subject(s)
Animals , Rats , Organotechnetium Compounds/chemical synthesis , Glucose/chemistry , Isotope Labeling/methods , Radiopharmaceuticals/chemical synthesis , Cardiology/methods , Organotechnetium Compounds/pharmacokinetics , Tissue Distribution , Time Factors , Glucose/analogs & derivatives , Ligands , Nuclear Medicine/methods , Medical Oncology/methods , Radiopharmaceuticals/pharmacokinetics , Technetium/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL